TGAC Appoints New Director
News Dec 09, 2015
Professor Neil Hall will join TGAC in April 2016 from the University of Liverpool where he is currently the Director of The Centre for Genomic Research.
As a leader in the field of genomics, Professor Hall has specialised in understanding the genomics of infectious disease over the past decade. He has led projects at The Wellcome Trust Sanger Institute and The Institute for Genomic Research (TIGR) in the US, including the effort to sequence the genome of Plasmodium falciparum, the malaria parasite.
Professor Hall, who is also Head of the Department of Comparative and Functional Genomics, gained his PhD in Genetics at Liverpool University. His current research interests range from investigating the genetics of pathogen population structures to developing genomic tools to assay complex genomes such as wheat, a crop of significant interest and research focus at TGAC.
Professor Nigel Brown, TGAC’s Board of Trustees’ Chair, said: “I am delighted that Professor Neil Hall has accepted the position of Director of TGAC. His expertise and experience will bring strong and relevant leadership to the Institute. The Board of Trustee Directors and I look forward to working with him in taking the Institute forward.”
TGAC receives strategic funding from the Biotechnology and Biological Science Research Council (BBSRC) and, Professor Jackie Hunter, BBSRC Chief Executive, said: “TGAC represents an important UK National Capability, pioneering genomic and bioinformatics science that is helping to drive the development of the bioeconomy. I am very pleased to see the appointment of Professor Hall as TGAC’s new Director. He has a superb track record in both genomics tools development and in applying this to tackling bioscience challenges. His combination of experience, knowledge and leadership make him the right person to lead TGAC.”
Professor Hall, said: “I am really excited to take on the role of Director. TGAC’s unique capability means it is exceptionally well placed to address some of the key challenges in the biosciences. I expect the Institute to have an expanding role in the research landscape, nationally and internationally, over the coming years. I have been impressed with the level of development at TGAC since its inception, and I am looking forward to join such an enthusiastic and energetic institute and to lead it to the next stage of development.”
Neil will take over from Interim Director, Professor Dylan Edwards who has been working at the Institute since August 2015. Professor Edwards will commence a new role in February 2016, at the University of East Anglia, as Executive Dean of the Faculty of Medicine and Health Sciences. Professor Edwards, said: “I am extremely pleased to see Professor Hall being appointed as Director at TGAC; since my time working with the team at the Institute I have been tremendously impressed with the world class research being delivered there. I will also look forward to continuing my close working relationship with the science faculty as part of the wider Norwich Research Park.”
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE